September 2018 - Volume 4 - Issue 9
pp: e380-e385

Efficacy and Safety of a Tofacitinib-based Immunosuppressive Regimen After Kidney Transplantation: Results From a Long-term Extension Trial

Busque, Stephan; Vincenti, Flavio G.; Tedesco Silva, Helio; More

Transplantation Direct. 4(9):e380, September 2018.

Autologous Mesenchymal Stromal Cells Prevent Transfusion-elicited Sensitization and Upregulate Transitional and Regulatory B Cells

Zhang, Zijian; Wilson, Nancy A.; Chinnadurai, Raghavan; More

Transplantation Direct. 4(9):e387, September 2018.

Donor-derived Cell-free DNA Identifies Antibody-mediated Rejection in Donor Specific Antibody Positive Kidney Transplant Recipients

Jordan, Stanley C.; Bunnapradist, Suphamai; Bromberg, Jonathan S.; More

Transplantation Direct. 4(9):e379, September 2018.


Identification and Validation of the Predictive Capacity of Risk Factors and Models in Liver Transplantation Over Time

Blok, Joris J.; Putter, Hein; Metselaar, Herold J.; More

Transplantation Direct. 4(9):e382, September 2018.



Anti-HLA Donor-Specific IgG Subclasses and C1q-binding Evolution in Posttransplant Monitoring

Ponsirenas, Renata von Glehn; Cazarote, Helena B.; Araújo, Stanley de Almeida; More

Transplantation Direct. 4(9):e385, September 2018.